Cold & Cough Remedies - Nepal

  • Nepal
  • In Nepal, the revenue generated in the Cold & Cough Remedies market market amounted to US$55.37m in 2024.
  • It is projected that the market will experience an annual growth rate of 10.06% (CAGR 2024-2029).
  • When compared to other countries worldwide, the in the United States leads the market with a revenue of US$11,190.00m in 2024.
  • In terms of per person revenues, in Nepal generated US$1.77 in 2024, taking into account the total population figures.
  • Nepal's growing demand for traditional herbal remedies is driving the market for Cold & Cough Remedies in the OTC Pharmaceuticals sector.

Key regions: Australia, Japan, India, Brazil, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Nepal has been experiencing significant growth in recent years.

Customer preferences:
Nepal is a country with a high prevalence of cold and cough-related illnesses, due to its mountainous terrain and cold climate. As a result, there is a strong demand for cold and cough remedies among the Nepalese population. Customers in Nepal typically prefer natural and herbal remedies for treating cold and cough symptoms, as they are seen as safer and more effective than pharmaceutical alternatives. This preference for natural remedies has led to the growth of the herbal cold and cough remedies segment in the market.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Nepal is the increasing popularity of Ayurvedic medicines. Ayurveda, a traditional system of medicine in Nepal, emphasizes the use of natural ingredients and holistic approaches to treat illnesses. Ayurvedic cold and cough remedies, which are derived from herbs and plants, have gained popularity among Nepalese consumers due to their perceived effectiveness and minimal side effects. As a result, there has been a growing demand for Ayurvedic cold and cough remedies in the market.Another trend in the market is the rising awareness and adoption of Western pharmaceutical cold and cough remedies. With increasing urbanization and exposure to Western lifestyles, Nepalese consumers are becoming more open to using pharmaceutical cold and cough remedies. These products are often seen as more convenient and reliable compared to traditional remedies. As a result, there has been a steady increase in the sales of Western pharmaceutical cold and cough remedies in Nepal.

Local special circumstances:
Nepal is a landlocked country with limited access to healthcare facilities, especially in rural areas. This has resulted in a reliance on over-the-counter cold and cough remedies for self-medication. Nepalese consumers often prefer to treat their cold and cough symptoms at home rather than seeking medical advice. This has created a strong demand for over-the-counter cold and cough remedies in the market.

Underlying macroeconomic factors:
The growing middle class and increasing disposable income in Nepal have played a significant role in the development of the Cold & Cough Remedies market. As people have more money to spend on healthcare products, the demand for cold and cough remedies has increased. Additionally, the rapid urbanization and changing lifestyles have led to an increase in the number of people exposed to pollution and other environmental factors that can cause cold and cough symptoms. This has further fueled the demand for cold and cough remedies in the market.In conclusion, the Cold & Cough Remedies market in Nepal is experiencing growth due to customer preferences for natural and herbal remedies, the increasing popularity of Ayurvedic medicines, the rising awareness and adoption of Western pharmaceutical remedies, the reliance on over-the-counter remedies for self-medication, and the underlying macroeconomic factors such as the growing middle class and increasing disposable income.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)